Management of diabetic dyslipidemia

Maria Del Pilar Solano, Ronald B. Goldberg

Research output: Contribution to journalReview article

34 Scopus citations

Abstract

Identification and management of dyslipidemia is an important element in the multi-factorial approach to prevent coronary heart disease. Diabetic dyslipidemia typically consists of elevated triglyceride, low high-density lipoprotein cholesterol, predominance of small, dense low-density lipoprotein (LDL) particles, and average LDL cholesterol (LDL-C). Lipid-lowering therapy has a beneficial effect on cardiovascular outcomes. Statin treatment is beneficial in patients who are older than 40 years of age, irrespective of the LDL-C value. To achieve lipid targets, attention should be directed first toward nonpharmacologic therapeutic interventions, such as diet, exercise, smoking cessation, weight loss, and improving glycemic control. Although statin therapy is recommended for most subjects, judicious use of combination therapy should be considered in the highest risk subjects.

Original languageEnglish (US)
Pages (from-to)1-25
Number of pages25
JournalEndocrinology and Metabolism Clinics of North America
Volume34
Issue number1
DOIs
StatePublished - Mar 2005

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Management of diabetic dyslipidemia'. Together they form a unique fingerprint.

  • Cite this